Joseph Maddry
Concepts (349)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Military Personnel | 42 | 2024 | 747 | 6.450 |
Why?
| | Air Ambulances | 17 | 2025 | 58 | 4.760 |
Why?
| | Emergency Medical Services | 31 | 2025 | 696 | 4.230 |
Why?
| | Afghan Campaign 2001- | 27 | 2024 | 195 | 3.360 |
Why?
| | Resuscitation | 14 | 2025 | 302 | 3.340 |
Why?
| | Wounds and Injuries | 23 | 2026 | 957 | 3.150 |
Why?
| | Critical Care | 16 | 2024 | 697 | 2.310 |
Why?
| | Iraq War, 2003-2011 | 19 | 2024 | 173 | 2.080 |
Why?
| | Military Medicine | 12 | 2025 | 149 | 1.760 |
Why?
| | Emergency Medicine | 7 | 2025 | 261 | 1.720 |
Why?
| | Hydroxocobalamin | 4 | 2023 | 33 | 1.640 |
Why?
| | Patient Transfer | 5 | 2019 | 206 | 1.620 |
Why?
| | Transportation of Patients | 5 | 2024 | 68 | 1.530 |
Why?
| | Compartment Syndromes | 2 | 2024 | 36 | 1.500 |
Why?
| | Trauma Centers | 4 | 2025 | 462 | 1.270 |
Why?
| | Ketamine | 8 | 2023 | 133 | 1.250 |
Why?
| | Patient Handoff | 2 | 2020 | 43 | 1.240 |
Why?
| | Antidotes | 6 | 2021 | 145 | 1.220 |
Why?
| | War-Related Injuries | 9 | 2019 | 46 | 1.210 |
Why?
| | Warfare | 7 | 2020 | 101 | 1.170 |
Why?
| | Respiration, Artificial | 4 | 2024 | 708 | 1.120 |
Why?
| | Hemorrhage | 9 | 2025 | 809 | 1.120 |
Why?
| | Shock, Hemorrhagic | 5 | 2025 | 201 | 1.110 |
Why?
| | Brain Injuries, Traumatic | 4 | 2025 | 441 | 1.090 |
Why?
| | Tourniquets | 2 | 2018 | 34 | 1.050 |
Why?
| | Thoracotomy | 2 | 2025 | 83 | 1.050 |
Why?
| | Hemodynamics | 9 | 2025 | 1121 | 1.020 |
Why?
| | Airway Management | 8 | 2021 | 79 | 1.000 |
Why?
| | Swine | 17 | 2026 | 833 | 0.970 |
Why?
| | Intubation, Intratracheal | 11 | 2025 | 320 | 0.970 |
Why?
| | Remote Consultation | 3 | 2018 | 66 | 0.930 |
Why?
| | Laryngoscopes | 5 | 2025 | 45 | 0.920 |
Why?
| | Toxicology | 2 | 2016 | 49 | 0.900 |
Why?
| | Heart Injuries | 1 | 2025 | 42 | 0.890 |
Why?
| | Heart Arrest | 5 | 2022 | 407 | 0.860 |
Why?
| | Wounds, Penetrating | 1 | 2025 | 72 | 0.850 |
Why?
| | Fasciotomy | 1 | 2024 | 23 | 0.840 |
Why?
| | Antivenins | 1 | 2024 | 29 | 0.840 |
Why?
| | Humans | 109 | 2026 | 144957 | 0.830 |
Why?
| | Hospitals, Military | 3 | 2020 | 31 | 0.830 |
Why?
| | Snake Bites | 1 | 2024 | 24 | 0.830 |
Why?
| | Afghanistan | 17 | 2024 | 96 | 0.810 |
Why?
| | Prospective Studies | 24 | 2026 | 7997 | 0.800 |
Why?
| | Apnea | 3 | 2020 | 25 | 0.790 |
Why?
| | Retrospective Studies | 34 | 2024 | 17101 | 0.790 |
Why?
| | Anesthetics, Dissociative | 1 | 2023 | 46 | 0.780 |
Why?
| | Simulation Training | 3 | 2021 | 134 | 0.780 |
Why?
| | Physicians | 5 | 2024 | 940 | 0.760 |
Why?
| | Balloon Occlusion | 2 | 2025 | 39 | 0.740 |
Why?
| | Disease Models, Animal | 14 | 2026 | 4569 | 0.720 |
Why?
| | Sulfhydryl Compounds | 2 | 2020 | 189 | 0.680 |
Why?
| | Critical Illness | 5 | 2019 | 892 | 0.670 |
Why?
| | United States | 34 | 2024 | 15988 | 0.650 |
Why?
| | Aorta, Abdominal | 2 | 2018 | 52 | 0.650 |
Why?
| | Adult | 47 | 2024 | 40506 | 0.650 |
Why?
| | Male | 59 | 2025 | 72406 | 0.650 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2024 | 383 | 0.620 |
Why?
| | Emergency Service, Hospital | 14 | 2024 | 2313 | 0.610 |
Why?
| | Cobamides | 4 | 2020 | 25 | 0.590 |
Why?
| | Drug Dosage Calculations | 1 | 2019 | 27 | 0.580 |
Why?
| | Texas | 6 | 2024 | 278 | 0.580 |
Why?
| | Injury Severity Score | 10 | 2024 | 600 | 0.570 |
Why?
| | Amputation, Traumatic | 1 | 2018 | 21 | 0.550 |
Why?
| | Medication Errors | 1 | 2019 | 83 | 0.550 |
Why?
| | Hypotension | 6 | 2023 | 126 | 0.550 |
Why?
| | Burns | 1 | 2023 | 377 | 0.540 |
Why?
| | Endovascular Procedures | 2 | 2025 | 384 | 0.530 |
Why?
| | Analgesics | 6 | 2020 | 231 | 0.530 |
Why?
| | Female | 53 | 2025 | 78376 | 0.530 |
Why?
| | Hemostatic Techniques | 1 | 2018 | 51 | 0.520 |
Why?
| | Biomedical Research | 1 | 2024 | 710 | 0.520 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2019 | 257 | 0.510 |
Why?
| | Guideline Adherence | 4 | 2024 | 589 | 0.500 |
Why?
| | Calcium Gluconate | 1 | 2016 | 4 | 0.500 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2016 | 52 | 0.490 |
Why?
| | Emergency Medical Technicians | 1 | 2016 | 43 | 0.480 |
Why?
| | Hypocalcemia | 1 | 2016 | 38 | 0.480 |
Why?
| | Altitude | 1 | 2020 | 473 | 0.470 |
Why?
| | Registries | 20 | 2024 | 2385 | 0.470 |
Why?
| | Heart Diseases | 1 | 2019 | 350 | 0.470 |
Why?
| | Iraq | 10 | 2020 | 66 | 0.460 |
Why?
| | Polyradiculopathy | 1 | 2015 | 3 | 0.460 |
Why?
| | Patient Simulation | 2 | 2018 | 41 | 0.460 |
Why?
| | Spinal Cord Compression | 1 | 2015 | 22 | 0.450 |
Why?
| | Animals | 24 | 2026 | 38109 | 0.450 |
Why?
| | Telemedicine | 2 | 2015 | 948 | 0.440 |
Why?
| | Poison Control Centers | 5 | 2024 | 84 | 0.440 |
Why?
| | Emergency Treatment | 3 | 2023 | 124 | 0.430 |
Why?
| | Hydrogen Sulfide | 3 | 2020 | 48 | 0.420 |
Why?
| | Hypothermia | 3 | 2024 | 52 | 0.420 |
Why?
| | Craniocerebral Trauma | 3 | 2022 | 176 | 0.410 |
Why?
| | Blood Transfusion | 4 | 2025 | 405 | 0.410 |
Why?
| | Time Factors | 5 | 2020 | 7183 | 0.410 |
Why?
| | Cardiopulmonary Resuscitation | 4 | 2022 | 342 | 0.400 |
Why?
| | Young Adult | 15 | 2024 | 14126 | 0.400 |
Why?
| | Hematemesis | 1 | 2012 | 4 | 0.380 |
Why?
| | Stomach Diseases | 1 | 2012 | 20 | 0.380 |
Why?
| | beta-Alanine | 1 | 2012 | 23 | 0.380 |
Why?
| | Sus scrofa | 4 | 2024 | 64 | 0.380 |
Why?
| | Citalopram | 1 | 2012 | 32 | 0.370 |
Why?
| | Antithrombins | 1 | 2012 | 70 | 0.360 |
Why?
| | Medical Records | 3 | 2023 | 189 | 0.360 |
Why?
| | Hyperoxia | 2 | 2025 | 99 | 0.350 |
Why?
| | Benzimidazoles | 1 | 2012 | 190 | 0.340 |
Why?
| | Education, Medical | 1 | 2014 | 276 | 0.340 |
Why?
| | Tranexamic Acid | 2 | 2023 | 53 | 0.330 |
Why?
| | Tachycardia, Ventricular | 1 | 2012 | 181 | 0.320 |
Why?
| | Self-Injurious Behavior | 1 | 2012 | 142 | 0.320 |
Why?
| | Referral and Consultation | 1 | 2016 | 853 | 0.320 |
Why?
| | Lung | 2 | 2020 | 4109 | 0.310 |
Why?
| | Aerospace Medicine | 3 | 2018 | 33 | 0.300 |
Why?
| | Blast Injuries | 2 | 2021 | 63 | 0.300 |
Why?
| | Mass Casualty Incidents | 2 | 2022 | 48 | 0.300 |
Why?
| | Analgesics, Opioid | 4 | 2020 | 1143 | 0.300 |
Why?
| | Laryngoscopy | 3 | 2025 | 117 | 0.300 |
Why?
| | Drug Overdose | 3 | 2012 | 370 | 0.290 |
Why?
| | Internship and Residency | 2 | 2021 | 1257 | 0.280 |
Why?
| | Pain | 3 | 2018 | 782 | 0.280 |
Why?
| | Aircraft | 2 | 2025 | 23 | 0.270 |
Why?
| | Point-of-Care Systems | 2 | 2021 | 187 | 0.270 |
Why?
| | Algorithms | 2 | 2026 | 1839 | 0.250 |
Why?
| | Airway Obstruction | 2 | 2019 | 162 | 0.240 |
Why?
| | Shock, Traumatic | 2 | 2023 | 15 | 0.240 |
Why?
| | Hematinics | 1 | 2026 | 22 | 0.230 |
Why?
| | Pneumothorax | 1 | 2026 | 51 | 0.230 |
Why?
| | Gases | 2 | 2023 | 53 | 0.230 |
Why?
| | Antifibrinolytic Agents | 2 | 2023 | 62 | 0.220 |
Why?
| | Erythropoietin | 1 | 2026 | 100 | 0.220 |
Why?
| | Wound Infection | 1 | 2025 | 57 | 0.210 |
Why?
| | Crotalinae | 1 | 2024 | 1 | 0.210 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 866 | 0.210 |
Why?
| | Child, Preschool | 7 | 2024 | 11799 | 0.210 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 129 | 0.210 |
Why?
| | Triage | 3 | 2022 | 249 | 0.210 |
Why?
| | Germany | 1 | 2024 | 138 | 0.210 |
Why?
| | Crotalid Venoms | 1 | 2024 | 32 | 0.210 |
Why?
| | Random Allocation | 3 | 2020 | 363 | 0.200 |
Why?
| | Blood Component Removal | 1 | 2024 | 28 | 0.200 |
Why?
| | Seasons | 2 | 2024 | 556 | 0.200 |
Why?
| | Middle Aged | 10 | 2024 | 35928 | 0.200 |
Why?
| | Isotonic Solutions | 1 | 2023 | 39 | 0.200 |
Why?
| | Treatment Outcome | 10 | 2023 | 11695 | 0.190 |
Why?
| | Chi-Square Distribution | 3 | 2019 | 529 | 0.190 |
Why?
| | Ventilators, Mechanical | 1 | 2023 | 70 | 0.190 |
Why?
| | Adolescent | 9 | 2024 | 22453 | 0.180 |
Why?
| | Fibrinolysis | 1 | 2023 | 162 | 0.180 |
Why?
| | Infusions, Intravenous | 2 | 2020 | 423 | 0.180 |
Why?
| | Acidosis | 1 | 2023 | 105 | 0.180 |
Why?
| | Fluid Therapy | 1 | 2023 | 147 | 0.180 |
Why?
| | Renal Insufficiency | 1 | 2024 | 169 | 0.180 |
Why?
| | Wounds, Nonpenetrating | 2 | 2025 | 316 | 0.180 |
Why?
| | Education, Medical, Graduate | 2 | 2024 | 557 | 0.170 |
Why?
| | Methanol | 2 | 2023 | 46 | 0.170 |
Why?
| | Thiosulfates | 1 | 2021 | 19 | 0.170 |
Why?
| | Ultrasonography | 2 | 2026 | 770 | 0.170 |
Why?
| | Amitriptyline | 2 | 2011 | 24 | 0.170 |
Why?
| | Antidepressive Agents, Tricyclic | 2 | 2011 | 31 | 0.170 |
Why?
| | Extremities | 1 | 2022 | 140 | 0.170 |
Why?
| | Analgesia | 2 | 2018 | 105 | 0.160 |
Why?
| | Research | 3 | 2022 | 431 | 0.160 |
Why?
| | Shock | 1 | 2022 | 108 | 0.160 |
Why?
| | Injections, Intramuscular | 4 | 2023 | 141 | 0.160 |
Why?
| | Etomidate | 1 | 2020 | 18 | 0.160 |
Why?
| | Cyanides | 1 | 2021 | 56 | 0.160 |
Why?
| | Occupations | 1 | 2020 | 51 | 0.160 |
Why?
| | Physician Assistants | 1 | 2022 | 102 | 0.160 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2020 | 17 | 0.160 |
Why?
| | Medical Errors | 2 | 2020 | 118 | 0.160 |
Why?
| | Thiadiazoles | 1 | 2020 | 27 | 0.160 |
Why?
| | Fellowships and Scholarships | 1 | 2024 | 357 | 0.150 |
Why?
| | Surveys and Questionnaires | 3 | 2025 | 6053 | 0.150 |
Why?
| | Hypovolemia | 1 | 2019 | 12 | 0.150 |
Why?
| | Blood Pressure | 2 | 2023 | 1769 | 0.150 |
Why?
| | Opioid-Related Disorders | 2 | 2018 | 601 | 0.150 |
Why?
| | Heart Rate | 1 | 2023 | 855 | 0.150 |
Why?
| | Heart Massage | 1 | 2019 | 11 | 0.150 |
Why?
| | Pain Management | 2 | 2020 | 405 | 0.150 |
Why?
| | Clinical Protocols | 2 | 2018 | 282 | 0.150 |
Why?
| | Aorta, Thoracic | 2 | 2020 | 286 | 0.150 |
Why?
| | Armed Conflicts | 1 | 2019 | 15 | 0.150 |
Why?
| | Survival Analysis | 5 | 2019 | 1385 | 0.140 |
Why?
| | Spinal Injuries | 1 | 2019 | 58 | 0.140 |
Why?
| | Aged | 7 | 2024 | 25947 | 0.140 |
Why?
| | Eating | 2 | 2023 | 392 | 0.140 |
Why?
| | Documentation | 1 | 2020 | 199 | 0.140 |
Why?
| | Succinylcholine | 1 | 2018 | 5 | 0.140 |
Why?
| | Child | 8 | 2024 | 22657 | 0.140 |
Why?
| | Norepinephrine | 1 | 2019 | 196 | 0.140 |
Why?
| | Databases, Factual | 1 | 2024 | 1486 | 0.140 |
Why?
| | Torso | 1 | 2018 | 36 | 0.140 |
Why?
| | Ethanol | 1 | 2023 | 627 | 0.140 |
Why?
| | Military Facilities | 1 | 2017 | 4 | 0.140 |
Why?
| | Administration, Intravenous | 4 | 2019 | 170 | 0.130 |
Why?
| | Tablets | 1 | 2017 | 41 | 0.130 |
Why?
| | Military Nursing | 1 | 2018 | 29 | 0.130 |
Why?
| | Clinical Competence | 4 | 2025 | 1244 | 0.130 |
Why?
| | Hydrocodone | 1 | 2017 | 17 | 0.130 |
Why?
| | Exanthema | 1 | 2018 | 84 | 0.130 |
Why?
| | Cervical Vertebrae | 1 | 2019 | 158 | 0.130 |
Why?
| | Cardiovascular Agents | 1 | 2019 | 164 | 0.130 |
Why?
| | Hemostatics | 1 | 2018 | 61 | 0.130 |
Why?
| | Tidal Volume | 1 | 2018 | 111 | 0.130 |
Why?
| | Tracheostomy | 1 | 2019 | 142 | 0.130 |
Why?
| | Dextromethorphan | 1 | 2016 | 24 | 0.120 |
Why?
| | Hydrofluoric Acid | 1 | 2016 | 7 | 0.120 |
Why?
| | Pelvis | 1 | 2018 | 124 | 0.120 |
Why?
| | Ammonium Compounds | 1 | 2016 | 4 | 0.120 |
Why?
| | Headache | 1 | 2017 | 150 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 189 | 0.120 |
Why?
| | Epidemics | 1 | 2018 | 98 | 0.120 |
Why?
| | Abdominal Injuries | 1 | 2018 | 127 | 0.120 |
Why?
| | Abdomen | 1 | 2017 | 141 | 0.120 |
Why?
| | Morphine | 4 | 2019 | 171 | 0.120 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 90 | 0.120 |
Why?
| | Fluorides | 1 | 2016 | 49 | 0.120 |
Why?
| | Ventricular Fibrillation | 1 | 2016 | 64 | 0.120 |
Why?
| | Wounds, Gunshot | 1 | 2020 | 258 | 0.120 |
Why?
| | Inpatients | 1 | 2020 | 546 | 0.120 |
Why?
| | Cohort Studies | 2 | 2024 | 5965 | 0.120 |
Why?
| | Personal Protective Equipment | 1 | 2016 | 57 | 0.120 |
Why?
| | Milk | 1 | 2016 | 119 | 0.120 |
Why?
| | Pandemics | 1 | 2024 | 1695 | 0.110 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 134 | 0.110 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 216 | 0.110 |
Why?
| | Communicable Disease Control | 1 | 2016 | 86 | 0.110 |
Why?
| | Chronic Pain | 1 | 2020 | 292 | 0.110 |
Why?
| | Urinary Retention | 1 | 2015 | 25 | 0.110 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2016 | 81 | 0.110 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 863 | 0.110 |
Why?
| | Survival Rate | 2 | 2018 | 2092 | 0.110 |
Why?
| | Patient Safety | 1 | 2019 | 349 | 0.110 |
Why?
| | Thoracic Vertebrae | 1 | 2015 | 79 | 0.110 |
Why?
| | Analysis of Variance | 1 | 2017 | 1311 | 0.110 |
Why?
| | United States Department of Defense | 3 | 2019 | 21 | 0.110 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1325 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1915 | 0.110 |
Why?
| | Oxygen | 1 | 2019 | 995 | 0.100 |
Why?
| | Nurses | 1 | 2016 | 178 | 0.100 |
Why?
| | Low Back Pain | 1 | 2015 | 107 | 0.100 |
Why?
| | Communication | 1 | 2020 | 967 | 0.100 |
Why?
| | Lumbar Vertebrae | 1 | 2015 | 252 | 0.100 |
Why?
| | Pilot Projects | 3 | 2026 | 1890 | 0.100 |
Why?
| | Health Personnel | 2 | 2018 | 748 | 0.100 |
Why?
| | Dabigatran | 1 | 2012 | 29 | 0.090 |
Why?
| | Video Recording | 2 | 2025 | 213 | 0.090 |
Why?
| | Fatal Outcome | 1 | 2012 | 307 | 0.090 |
Why?
| | Fentanyl | 3 | 2018 | 127 | 0.090 |
Why?
| | Lower Extremity | 1 | 2015 | 438 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1358 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2015 | 1495 | 0.080 |
Why?
| | Infant, Newborn | 2 | 2021 | 6434 | 0.080 |
Why?
| | Diphenhydramine | 1 | 2010 | 36 | 0.080 |
Why?
| | Calcium | 1 | 2016 | 1184 | 0.080 |
Why?
| | Hypoxia | 1 | 2018 | 1199 | 0.080 |
Why?
| | Infant | 3 | 2021 | 10039 | 0.080 |
Why?
| | Electrocardiography | 1 | 2012 | 663 | 0.070 |
Why?
| | Quality Improvement | 1 | 2018 | 1291 | 0.070 |
Why?
| | Incidence | 4 | 2019 | 2883 | 0.070 |
Why?
| | Logistic Models | 2 | 2024 | 2119 | 0.060 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2006 | 194 | 0.060 |
Why?
| | Pain Measurement | 2 | 2018 | 555 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2006 | 337 | 0.050 |
Why?
| | Feedback | 1 | 2025 | 181 | 0.050 |
Why?
| | Equipment Reuse | 1 | 2024 | 18 | 0.050 |
Why?
| | Anemia | 1 | 2026 | 188 | 0.050 |
Why?
| | Genetic Therapy | 1 | 2006 | 313 | 0.050 |
Why?
| | Viruses | 1 | 2006 | 165 | 0.050 |
Why?
| | Ambulances | 1 | 2023 | 53 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3869 | 0.050 |
Why?
| | Practice Guidelines as Topic | 1 | 2010 | 1563 | 0.050 |
Why?
| | South Africa | 1 | 2023 | 261 | 0.040 |
Why?
| | Hawaii | 1 | 2022 | 46 | 0.040 |
Why?
| | Aorta | 1 | 2025 | 430 | 0.040 |
Why?
| | Vital Signs | 1 | 2022 | 48 | 0.040 |
Why?
| | Japan | 1 | 2022 | 143 | 0.040 |
Why?
| | Blood Coagulation Disorders | 1 | 2023 | 189 | 0.040 |
Why?
| | Prognosis | 2 | 2021 | 4293 | 0.040 |
Why?
| | Pressure | 1 | 2022 | 225 | 0.040 |
Why?
| | Hospitalization | 2 | 2024 | 2434 | 0.040 |
Why?
| | Cadaver | 1 | 2022 | 304 | 0.040 |
Why?
| | Appointments and Schedules | 1 | 2021 | 97 | 0.040 |
Why?
| | Infusions, Intraosseous | 1 | 2020 | 19 | 0.040 |
Why?
| | Arterial Pressure | 1 | 2021 | 136 | 0.040 |
Why?
| | Abbreviated Injury Scale | 1 | 2019 | 27 | 0.040 |
Why?
| | Primary Health Care | 2 | 2021 | 1734 | 0.040 |
Why?
| | Intersectoral Collaboration | 1 | 2020 | 62 | 0.040 |
Why?
| | Inhalation Exposure | 1 | 2020 | 115 | 0.040 |
Why?
| | Prescription Drug Misuse | 1 | 2020 | 51 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2006 | 1126 | 0.040 |
Why?
| | Pulse | 1 | 2019 | 27 | 0.040 |
Why?
| | Syria | 1 | 2019 | 5 | 0.040 |
Why?
| | Models, Animal | 1 | 2021 | 392 | 0.040 |
Why?
| | Monitoring, Physiologic | 1 | 2021 | 289 | 0.040 |
Why?
| | Echocardiography | 1 | 2022 | 652 | 0.040 |
Why?
| | Trauma Severity Indices | 1 | 2018 | 112 | 0.030 |
Why?
| | Administration, Oral | 1 | 2021 | 848 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2018 | 200 | 0.030 |
Why?
| | Dextropropoxyphene | 1 | 2017 | 4 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2020 | 601 | 0.030 |
Why?
| | Sex Distribution | 1 | 2019 | 386 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2020 | 285 | 0.030 |
Why?
| | Tramadol | 1 | 2017 | 17 | 0.030 |
Why?
| | Glasgow Coma Scale | 1 | 2018 | 213 | 0.030 |
Why?
| | Catheterization, Peripheral | 1 | 2019 | 119 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2022 | 760 | 0.030 |
Why?
| | Shock, Septic | 1 | 2019 | 216 | 0.030 |
Why?
| | Developing Countries | 1 | 2019 | 318 | 0.030 |
Why?
| | Human Experimentation | 1 | 2016 | 12 | 0.030 |
Why?
| | Sodium Chloride | 1 | 2017 | 142 | 0.030 |
Why?
| | Telephone | 1 | 2017 | 175 | 0.030 |
Why?
| | Sulfides | 1 | 2017 | 92 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2019 | 724 | 0.030 |
Why?
| | Hydromorphone | 1 | 2016 | 10 | 0.030 |
Why?
| | Research Subjects | 1 | 2016 | 41 | 0.030 |
Why?
| | Ethics Committees, Research | 1 | 2016 | 41 | 0.030 |
Why?
| | Decision Support Systems, Clinical | 1 | 2020 | 265 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2018 | 966 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2836 | 0.030 |
Why?
| | Quality Assurance, Health Care | 1 | 2018 | 340 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2020 | 768 | 0.030 |
Why?
| | Educational Measurement | 1 | 2018 | 326 | 0.030 |
Why?
| | Travel | 1 | 2016 | 136 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2020 | 780 | 0.030 |
Why?
| | Infection Control | 1 | 2016 | 172 | 0.030 |
Why?
| | Program Evaluation | 1 | 2018 | 949 | 0.030 |
Why?
| | Curriculum | 1 | 2021 | 1060 | 0.030 |
Why?
| | Health Services Accessibility | 1 | 2021 | 1099 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2016 | 422 | 0.020 |
Why?
| | Qualitative Research | 1 | 2020 | 1671 | 0.020 |
Why?
| | Coma | 1 | 2010 | 38 | 0.020 |
Why?
| | Sleep Stages | 1 | 2010 | 75 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2880 | 0.020 |
Why?
| | Substance-Related Disorders | 1 | 2017 | 1094 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 4275 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2010 | 361 | 0.020 |
Why?
| | Genes, Viral | 1 | 2006 | 90 | 0.010 |
Why?
| | Lentivirus | 1 | 2006 | 60 | 0.010 |
Why?
| | Luciferases | 1 | 2006 | 152 | 0.010 |
Why?
| | Seizures | 1 | 2010 | 477 | 0.010 |
Why?
| | Genetic Engineering | 1 | 2006 | 93 | 0.010 |
Why?
| | Dependovirus | 1 | 2006 | 79 | 0.010 |
Why?
| | Adenoviridae | 1 | 2006 | 199 | 0.010 |
Why?
| | Plasmids | 1 | 2006 | 379 | 0.010 |
Why?
| | HeLa Cells | 1 | 2006 | 650 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2006 | 1268 | 0.010 |
Why?
| | Mice | 1 | 2020 | 18365 | 0.010 |
Why?
| | Hypertension | 1 | 2010 | 1264 | 0.010 |
Why?
| | Gene Expression | 1 | 2006 | 1490 | 0.010 |
Why?
| | Cell Line | 1 | 2006 | 2882 | 0.010 |
Why?
|
|
Maddry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|